Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · Real-Time Price · USD
0.970
-0.030 (-3.00%)
Dec 20, 2024, 4:00 PM EST - Market closed
Akari Therapeutics, Market Cap
Akari Therapeutics, has a market cap or net worth of $24.02 million as of December 20, 2024. Its market cap has increased by 27.58% in one year.
Market Cap
24.02M
Enterprise Value
22.77M
1-Year Change
27.58%
Ranking
Category
Stock Price
$0.97
Market Cap Chart
Since September 28, 2015, Akari Therapeutics,'s market cap has decreased from $291.48M to $24.02M, a decrease of -91.76%. That is a compound annual growth rate of -23.68%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gelteq | 25.67M |
| DarioHealth | 25.23M |
| Femasys | 25.19M |
| Lipocine | 25.03M |
| NeuroSense Therapeutics | 24.92M |
| Pluri | 24.46M |
| PolyPid | 23.81M |
| Longeveron | 23.74M |